Mediwound Ebitda vs Operating Income Analysis
| MDWD Stock | USD 16.48 0.28 1.67% |
Mediwound financial indicator trend analysis is infinitely more than just investigating Mediwound recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mediwound is a good investment. Please check the relationship between Mediwound Ebitda and its Operating Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
Ebitda vs Operating Income
Ebitda vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mediwound Ebitda account and Operating Income. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Mediwound's Ebitda and Operating Income is 0.8. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Operating Income in the same time period over historical financial statements of Mediwound, assuming nothing else is changed. The correlation between historical values of Mediwound's Ebitda and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Mediwound are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Ebitda i.e., Mediwound's Ebitda and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.8 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Ebitda
Operating Income
Operating Income is the amount of profit realized from Mediwound operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Mediwound is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from Mediwound's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mediwound current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.At present, Mediwound's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 145.1 M, whereas Issuance Of Capital Stock is forecasted to decline to about 21.9 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 903K | 8.9M | 427K | 405.7K | Depreciation And Amortization | 1.2M | 1.3M | 1.3M | 810.5K |
Mediwound fundamental ratios Correlations
Click cells to compare fundamentals
Mediwound Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mediwound fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Common Stock Shares Outstanding | 3.9M | 3.9M | 3.9M | 5.0M | 9.0M | 9.5M | |
| Total Assets | 40.6M | 31.1M | 19.7M | 50.0M | 66.5M | 44.6M | |
| Other Current Liab | 569K | 4.8M | 5.5M | 6.3M | 5.3M | 3.6M | |
| Total Current Liabilities | 10.4M | 8.3M | 10.7M | 12.1M | 10.8M | 7.6M | |
| Total Stockholder Equity | 15.2M | 7.3M | (4.6M) | 10.9M | 31.6M | 33.2M | |
| Other Liab | 13.0M | 13.8M | 12.2M | 26.2M | 23.6M | 15.9M | |
| Property Plant And Equipment Net | 4.5M | 4.5M | 4.0M | 3.6M | 15.9M | 16.7M | |
| Net Debt | (5.2M) | (15.6M) | (9.7M) | (33.0M) | (5.5M) | (5.8M) | |
| Retained Earnings | (125.8M) | (135.0M) | (148.5M) | (168.1M) | (174.8M) | (183.6M) | |
| Accounts Payable | 4.1M | 3.0M | 4.7M | 5.7M | 5.5M | 3.2M | |
| Cash | 7.2M | 17.4M | 11.0M | 33.9M | 11.9M | 20.9M | |
| Non Current Assets Total | 5.0M | 4.9M | 4.8M | 4.2M | 16.8M | 17.6M | |
| Non Currrent Assets Other | 6K | (4.9M) | (4.3M) | (3.8M) | 183K | 306.7K | |
| Other Assets | 48K | 6K | 469K | 364K | 327.6K | 311.2K | |
| Cash And Short Term Investments | 29.5M | 21.6M | 11.0M | 33.9M | 41.5M | 31.9M | |
| Net Receivables | 4.6M | 2.8M | 2.3M | 9.3M | 4.4M | 4.2M | |
| Liabilities And Stockholders Equity | 40.6M | 31.1M | 19.7M | 50.0M | 66.5M | 44.6M | |
| Non Current Liabilities Total | 15.0M | 15.5M | 13.6M | 27.0M | 16.4M | 16.5M | |
| Inventory | 1.6M | 1.4M | 1.2M | 2.0M | 2.8M | 1.7M | |
| Other Current Assets | 216K | 646K | 439K | 650K | 889K | 844.6K | |
| Other Stockholder Equity | 140.9M | 142.2M | 143.9M | 178.9M | 206.3M | 137.7M | |
| Total Liab | 25.4M | 23.8M | 24.3M | 39.1M | 34.9M | 31.0M | |
| Property Plant And Equipment Gross | 4.5M | 4.5M | 4.0M | 3.6M | 23.1M | 24.2M | |
| Total Current Assets | 35.6M | 26.2M | 15.0M | 45.8M | 49.7M | 38.0M | |
| Accumulated Other Comprehensive Income | (25K) | (17K) | (40K) | (19K) | (5K) | (18.9K) | |
| Intangible Assets | 429K | 363K | 297K | 231K | 165K | 156.8K | |
| Property Plant Equipment | 4.5M | 4.5M | 4.0M | 3.6M | 4.1M | 2.6M | |
| Net Tangible Assets | 14.7M | 6.9M | (4.9M) | 10.7M | 9.6M | 7.6M | |
| Short Term Investments | 0.0 | 16.9M | 22.0M | 4.0M | 29.7M | 31.2M | |
| Current Deferred Revenue | 249K | 462K | 543K | 63K | 24K | 22.8K | |
| Non Current Liabilities Other | 11.7M | 12.3M | 11.8M | 10.2M | 9.9M | 11.3M | |
| Net Invested Capital | 15.2M | 7.3M | (4.6M) | 10.9M | 31.6M | 33.2M | |
| Net Working Capital | 25.2M | 17.9M | 4.2M | 33.8M | 38.9M | 21.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 2.18 | Quarterly Revenue Growth 0.061 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.